- Home
- EDSA vs OMH Comparison
EDSA vs OMH Comparison
Compare EDSA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- OMH
- Stock Information
- Founded
- EDSA 2015
- OMH 2015
- Country
- EDSA Canada
- OMH Singapore
- Employees
- EDSA N/A
- OMH N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- OMH Real Estate
- Sector
- EDSA Health Care
- OMH Finance
- Exchange
- EDSA Nasdaq
- OMH Nasdaq
- Market Cap
- EDSA 6.2M
- OMH N/A
- IPO Year
- EDSA N/A
- OMH 2023
- Fundamental
- Price
- EDSA $2.45
- OMH $2.23
- Analyst Decision
- EDSA Strong Buy
- OMH Strong Buy
- Analyst Count
- EDSA 1
- OMH 1
- Target Price
- EDSA $21.00
- OMH $15.00
- AVG Volume (30 Days)
- EDSA 32.2K
- OMH 17.0K
- Earning Date
- EDSA 05-09-2025
- OMH 01-01-0001
- Dividend Yield
- EDSA N/A
- OMH N/A
- EPS Growth
- EDSA N/A
- OMH N/A
- EPS
- EDSA N/A
- OMH N/A
- Revenue
- EDSA N/A
- OMH $5,390,607.00
- Revenue This Year
- EDSA N/A
- OMH $111.47
- Revenue Next Year
- EDSA N/A
- OMH $32.08
- P/E Ratio
- EDSA N/A
- OMH N/A
- Revenue Growth
- EDSA N/A
- OMH 25.77
- 52 Week Low
- EDSA $1.55
- OMH $0.25
- 52 Week High
- EDSA $5.59
- OMH $2.70
- Technical
- Relative Strength Index (RSI)
- EDSA 53.34
- OMH 63.38
- Support Level
- EDSA $2.31
- OMH $2.12
- Resistance Level
- EDSA $2.55
- OMH $2.31
- Average True Range (ATR)
- EDSA 0.12
- OMH 0.23
- MACD
- EDSA -0.02
- OMH -0.07
- Stochastic Oscillator
- EDSA 48.28
- OMH 25.34
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.